Fulgent Genetics Inc (FLGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -411 | -115 | -1,577 | -1,908 | -5,607 |
| Depreciation Amortization | 2,213 | 1,601 | 1,090 | 572 | 2,460 |
| Income taxes - deferred | -21 | -21 | N/A | N/A | 36 |
| Accounts receivable | -839 | 588 | 368 | 1,414 | -1,970 |
| Accounts payable and accrued liabilities | -329 | -91 | -124 | 79 | 102 |
| Other Working Capital | -915 | 899 | 219 | 1,457 | -1,244 |
| Other Operating Activity | 5,819 | 2,772 | 1,754 | -559 | 5,548 |
| Operating Cash Flow | $5,517 | $5,633 | $1,730 | $1,055 | $-675 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -27,727 | 7,754 | 1,322 | -2,388 | 3,782 |
| PPE Investments | -1,182 | -721 | -633 | -134 | -2,832 |
| Purchase Of Investment | -137 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-29,046 | $7,033 | $689 | $-2,522 | $950 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 28,796 | 1,136 | 9 | 4 | 15 |
| Common Stock Repurchased | -21 | 0 | 0 | 0 | N/A |
| Financing Cash Flow | $28,775 | $1,136 | $9 | $4 | $15 |
| Exchange Rate Effect | -17 | -16 | 1 | 15 | -44 |
| Beginning Cash Position | 6,736 | 6,736 | 6,736 | 6,736 | 6,490 |
| End Cash Position | 11,965 | 20,522 | 9,165 | 5,288 | 6,736 |
| Net Cash Flow | $5,229 | $13,786 | $2,429 | $-1,448 | $246 |
| Free Cash Flow | |||||
| Operating Cash Flow | 5,517 | 5,633 | 1,730 | 1,055 | -675 |
| Capital Expenditure | -1,182 | -721 | -633 | -134 | -2,832 |
| Free Cash Flow | 4,335 | 4,912 | 1,097 | 921 | -3,507 |